CRISPR In Brief

CRISPR/Cas9 gene editing is fast, efficient and specific. How does it work?

CRISPR is a natural process that occurs within the bacteria's adaptive immune system, as one of the many defense mechanisms used by bacteria to protect against genetic invaders. Bacteria identify and store fragments of DNA from invading viruses. When the cell recognizes a new viral attack, it uses this stored DNA signature to synthetize the related RNA molecule, which works as a guide in tandem with Cas9, an endonuclease from the bacterium Streptococcus pyogenes, to make double-stranded cuts in the DNA of the bacteria-invading virus to disable it. The DNA signature, which contains repeating sequences of genetic code, interrupted by spacer sequences of genetic code from previous viral attacks, are called clustered regulatory interspaced short palindromic repeats, or CRISPR. The transition from this natural process in bacteria to potential human therapeutic use was enabled by the discovery of a second RNA strand in guiding Cas9 to make the cuts in the DNA. (Also see "Can CRISPR Make The Jump To Therapeutics?" - Scrip, 20 March, 2014.)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from In Vivo

Rising Leaders 2025: Emma Hodcroft On Taking Initiative When “Plan A” Falls Short

 

Emma Hodcroft, co-founder of Pathoplexus and a key Nextstrain contributor, stresses the importance of career flexibility for young scientists. She urges early-stage researchers to embrace curiosity, using her unconventional path as an example of how curiosity can lead to impactful success. 

How Ethris Cracked mRNA’s “Do Not Shake” Problem To Unlock Respiratory Therapeutics

 
• By 

A German biotech has solved a fundamental physics problem that has limited mRNA therapeutics to injectable vaccines. Its breakthrough stabilizer technology allows mRNA particles to survive the mechanical stress of inhalation delivery, opening the door to treating chronic respiratory diseases.

Execs On The Move: May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.